NCT06254781View on ClinicalTrials.gov

Luspatercept in Metastatic AGCT of the Ovary

NACompletedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

May 30, 2022

Primary Completion Date

August 22, 2022

Study Completion Date

August 29, 2022

Conditions

Adult Granulosa Cell Tumor of the Ovary

Interventions

DRUG

Luspatercept

Erythroid Maturation Agent

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER